The ACR/ARHP Nurse Practitioner and Physician Assistant Postgraduate Rheumatology Training Program is now open for registration. To date, over 60 experts have dedicated multiple hours to complete this innovative program. The program includes 18 hours of audio-annotated PowerPoint slides, over 2800 slides, and 631 images. The need for the program was identified through the ACR workforce study and a demand by ACR/ARHP members. This novel program will allow NPs, PAs, and others interested in rheumatology to have a flexible, affordable way to build competence in the care of persons with rheumatic diseases.
The web-based program consists of 19 modules organized into three tracks: core, adult, and pediatric. Registrants will need to complete the 6 core modules and then either 3 pediatric or 10 adult modules to receive a certificate of completion. Registrants can also take all 19 modules to receive a combined adult and pediatric certificate of completion.
The modules consist of several components. First, a pre-test or a pre-assessment of your knowledge about a specific topic in rheumatology is completed. Case studies allow for the person to enter in their own response and then learn how experts in the field would respond. Second, the lecture presentation includes audio-annotated Powerpoint slides. Each of the audio-annotations vary in length from 30 to 120 minutes. Third, clinical tip sheets (also known as clinical pearls) can be printed out for use in a clinic or practice setting. And fourth, a post-test allows the individual to test their knowledge of what they have learned. Current references are included for each module. The individual can spend as much time as they prefer on a given module and can complete each module in increments of time based on their personal schedule.
Registrants must receive a pass rate of 70% or greater on each module assessment to complete the module, all modules in their registered track must be completed within one year of registering for the Program. Once an individual has successfully passed each module assessment within their registered track, they will receive a “Certificate of Completion” for the track. Additionally, AMA PRA Category 1 Credits will be provided.
The registration fees are:
NP-PA Training Program Registration Fees
| |
ACR & ARHP Member |
Nonmember |
| Pediatric Track |
$900 |
$1200 |
| Adult Track |
$1200 |
$1500 |
| Combined Adult and Pediatric Track |
$1500 |
$1800 |
Join ARHP to Receive the Member Registration Discount
If you are not a member but are interested in receiving the member discount prices and additional ARHP member benefits, join today!
NP and PA Program Editorial Team
Members of the NP and PA Postgraduate Rheumatology Training Program Editorial Team are Basia Belza, PhD, RN (scientific editor); Peter Embi, MD, MS, Joan McTigue, PA-C, MS, and Debra Bancroft Rizzo, MSN, FNP (associate editors); and Aubrey Hale, Kelly Bell, and Melinda McRae (technology consultants).
Acknowledgments
The ARHP thanks Abbott Laboratories, Bristol-Myers Squibb Company, and Centocor, Inc. for providing educational grants for the development of the NP and PA Postgraduate Rheumatology Training Program.
Additional Information
For additional information about the NP and PA Postgraduate Rheumatology Training Program:
Contact , ARHP executive director or call him at (404) 633-3777, ext. 803.
Conflict of Interest / Disclosure Statements
As an educational provider accredited by the Accreditation Council for Continuing Medical Education (ACCME) it is the ACR’s policy to ensure balance, independence, objectivity, and scientific rigor in all its educational activities. Faculty participating in an ACR-sponsored activity must disclose to the editorial team and audience any financial or other relationship(s) including, but not limited to:
Stock, stock options or bond holdings in a for-profit corporation or self-directed pension plan
Research grants
Employment (full or part-time)
Ownership or partnership
Consulting fees or other remuneration (payment)
Non-remunerative positions of influence such as officer, board member, trustee or public spokesperson
Receipt of royalties
Speakers’ bureau
Other
Faculty disclosures listed apply in numeric format according to the list above. In accordance with ACR policy an individual who refuses to disclose relevant financial relationships will be disqualified from being a planning committee member, a teacher, or an author of CME, and cannot have control of, or responsibility for the development, management, presentation or evaluation of the CME activity.
The authors and editors reported the following disclosures:
Basia Belza, PhD, RN- Nothing to disclose.
Neal S Birnbaum, MD- Nothing to disclose.
Daniel F Battafarano, DO- Nothing to disclose.
Atul A Deodhar, MD, MRCP- Amgen 2, Centocor, Inc. 2, 5, 8, Genentech and Biogen IDEC Inc 2, 5, 8, Pfizer Inc 8.
Laurie E Ebner-Lyon, RN, MSN, APN C- Nothing to disclose.
N. Lawrence Edwards, MD- Savient Pharmaceutical 2, TAP Pharmaceuticals Inc. 5.
Peter J Embi, MD, MS, Nothing to disclose.
Donna K Everix, MPA BS PT- Nothing to disclose.
Gregory C Gardner, MD- Abbott Immunology Pharmaceuticals 5, Wyeth Pharmaceuticals 9
David J Hunter, MBBS, PhD- AstraZeneca 2, DJ Orthopedics 2, Merck Pharmaceuticals 2, Pfizer Inc 2.
Karen L Kerr, MSN, NP, CPNP, PNP-BC- Nothing to disclose.
Curry L Koening, MD MS- Nothing to disclose.
Meghavi Kosboth, DO- Nothing to disclose.
Carol A Langford, MD, MHS- Nothing to disclose.
Gail R McIlvain-Simpson, MSN, PNP, BC- Nothing to disclose.
Michael J Maricic, MD- Nothing to disclose.
Joan C McTigue, MS, PA-C- Nothing to disclose.
Victoria A Merrell, PA-C, MPT- Nothing to disclose.
Eamonn S. Molloy, MD, MRCPI- Nothing to disclose.
Mark D Murphey, MD- Nothing to disclose.
Stanley J Naides, MD- Quest Diagnostics, Incorporated 1, 3.
Chester V Oddis, MD- Nothing to disclose.
Murray H Passo, MD- Nothing to disclose.
Kate T Queen, MD- Nothing to disclose.
Deb Bancroft Rizzo, MSN, FNP- Nothing to disclose.
Miguel E Rodriguez, MD- Nothing to disclose.
Sandra Schuler, MD- Nothing to disclose.
Carol Stewart, DDS- Nothing to disclose.
Janalee Taylor, MSN RN CNP- Nothing to disclose.
Sima Terebelo, MPH, PA-C- Nothing to disclose.
Mark H Wener, MD- Nothing to disclose.
The reviewers reported the following disclosures:
Roy D Altman, MD- Nothing to disclose.
Catherine L Backman, PhD, OT(C)- Nothing to disclose.
Sanford Baim, MD- Nothing to disclose.
Antanya Chung, CPC - Nothing to disclose.
Melesia Collins, CPC- Nothing to disclose.
Chad L Deal, MD- Nothing to disclose.
Maura D Iversen, PT DPT SD MPH- Nothing to disclose.
Diane L Kamen, MD- Nothing to disclose.
Jonathan Kay, MD- Nothing to disclose.
Muhammad Asim A Khan, MD, MACP- Abbott Laboratories 8, Amgen 8, Centocor, Inc. 8, Schering Canada 8, Schering-Plough 8, Wyeth Pharmaceuticals 8
Dinesh Khanna, MD, MSc- Nothing to disclose.
Carol B Lindsley, MD- Nothing to disclose.
Brian F Mandell, MD, PhD- Nothing to disclose.
Richard S Pope, PA-C- Nothing to disclose.
John D Reveille, MD- Nothing to disclose.
Elizabeth L Roth-Wojcicki, RN, MS, CPNP- Nothing to disclose.
H. Ralph Schumacher, MD- Amgen 2, CherryPharm 2, Ipsen 5, Merck Human Health 2, 5, Pfizer Inc 5, TAP Pharmaceuticals Inc. 2, 2, 5, 8
David D Sherry, MD- Nothing to disclose.
Benjamin J Smith, PA-C- Abbott Laboratories 5
Doreen M Stiskal, PT PhD- Nothing to disclose.
John H Stone, MD, MPH- Nothing to disclose.
Vibeke Strand, MD- Abbott Laboratories 5, 8, 9, Amgen 5, 8, 9, Astellas 5, AstraZeneca 5, Biogen Idec 5, BMS 9, Canfite Pharma 5, Centocor, Inc. 5, 8, 9, Cypress Biosciences, Inc. 5, 5, Genelabs 5, Genentech and Biogen IDEC Inc 5, Human Genome Sciences, Inc. 5, Novartis 9, Novartis Pharmaceutical Corporation 5, Omeros 5, Pfizer Inc 5, 8, 9, Pharmacopeia 5, Proprius 5, Roche 5, 9, Sanofi Aventis 5, Schering Plough 5, Serono 5, SKK 5, Summitomo 5, UCB 5, 9, Wyeth Pharmaceuticals 5, Xdx 5
Sterling G West, MD- Nothing to disclose.
